Results 41 to 50 of about 64,598 (305)
Plinabulin, a new antitumor drug developed from marine natural products that targets microtubules in cancer cells, is currently being tested in a phase III clinical study. Plinabulin has been clinically proven to be effective on leukopenia.
Xiaochen Niu +4 more
doaj +1 more source
Leukopenia in kidney transplant patients [PDF]
Przedstawiono przypadek bezobjawowej leukopenii i agranulocytozy u pacjenta w piątym miesiącu potransplantacji nerki. Leukopenia najprawdopodobniej spowodowana była skojarzonym leczeniem walgancyklowirem i mykofenolanem mofetylu.Asymptomatic leukopenia ...
Wyzgał, Marcin, Ważna-Jabłońska, Ewa
core
Leukopenia Associated with Long-Term Colchicine Adminsitration [PDF]
Purpose A case of leukopenia in a patient receiving colchicine for calcium pyrophosphate dihydrate deposition disease, or pseudogout, is reported. Summary An 85-year-old man experienced leukopenia likely due to colchicine. His medical history included
Beggs, Ashton E. +2 more
core +1 more source
Objective Studies of damage accrual in patients with systemic lupus erythematosus (SLE) show associations with disease activity measured by the SLE Disease Activity Index 2000 (SLEDAI‐2K), but these associations are imperfect. SLEDAI scores are powerfully influenced by weightings (1–8) assigned to each domain.
Kevin Zhang +8 more
wiley +1 more source
Hematological Side Effects of Atypical Antipsychotic Drugs [PDF]
Atypical antipsychotics cause less frequently extrapyramidal system symptoms, neuroleptic malignant syndrome and hyperprolactinemia than typical antipsychotics.
Serap Erdogan
doaj
Leukopenia po przeszczepieniu narządów unaczynionych [PDF]
Leukopenia after solid organ transplantation (SOT) occurs at various times after transplantation even in half of recipients. The main causes of leukopenia after SOT iclude toxic effect of multidrug therapy on bone marrow, systemic infections and cancers.
Gala-Błądzińska, Agnieszka +1 more
core
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci +25 more
wiley +1 more source
Prognostic values of physical and hematological parameters of dogs naturally infected with parvovirus PVC-2: retrospective study of 103 cases [PDF]
Canine parvovirosis is a high mortality disease with acute clinical picture. However, there are few available resources to help stablish prognosis accurately.
F.S. Alves +5 more
doaj +1 more source
Leukopenia in the critically ill patient
The diagnosis of leukopenia can be particularly challenging in the critically ill patient, since a reduced number of white blood cells can be associated with many different systemic or hematological disorders.
AGBEDJRO, ANTOINETTE +5 more
core +1 more source
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo +4 more
wiley +1 more source

